Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
Clinical trial NCT01116128 · TERMINATED
Trial details
- NCT number
- NCT01116128
- Sponsor
- Fondazione EMN Italy Onlus
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2011-05-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.